Advances in the clinical management of uveal melanoma
2023 · Nature Reviews Clinical Oncology · 242 citations
https://doi.org/10.1038/s41571-022-00714-1
D
David J. Eschelman
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
131
Papers
2.8K
Citations
32
h-index
52
i10-index
David J. Eschelman is an academic researcher from Thomas Jefferson University. The author has contributed to research in topics: Ocular Oncology and Treatments & Immunotherapy and Immune Responses & Radiation Dose and Imaging. The author has an h-index of 32, co-authored 112 publications.
Papers by this author
worksComplications of a Percutaneous Suture-mediated Closure Device versus Manual Compression for Arteriotomy Closure: A Case-controlled Study
2003 · Journal of Vascular and Interventional Radiology · 47 citations
https://doi.org/10.1097/01.rvi.0000079982.80153.d9
Efficacy and Safety of the Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma: Results from an Open-Label, Single-Arm, Multicenter Phase 3 Study
2024 · Annals of Surgical Oncology · 38 citations
https://doi.org/10.1245/s10434-024-15293-x
Subgroup analyses of the phase 3 FOCUS study of melphalan/hepatic delivery system in patients with unresectable metastatic uveal melanoma
2025 · Journal of Cancer Research and Clinical Oncology · 0 citations
https://doi.org/10.1007/s00432-025-06291-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat